[4-(benzo [b] thiophen-2-yl) pyrimidin2yl] -amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases.

Details for Australian Patent Application No. 2006337626 (hide)

Owner Eli Lilly and Company

Inventors Richett, Michael Enrico; Wang, Q May; Zhang, Bo; Dahnke, Karl Robert; Shih, Chuan; Lin, Ho-shen

Agent Spruson & Ferguson

Pub. Number AU-B-2006337626

PCT Pub. Number WO2007/092095

Priority 60/738,097 18.11.05 US

Filing date 15 November 2006

Wipo publication date 16 August 2007

Acceptance publication date 22 March 2012

International Classifications

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 33/00 (2006.01) Antiparasitic agents

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/092095 Priority application(s): WO2007/092095

22 March 2012 Application Accepted

  Published as AU-B-2006337626

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006337627-Apparatus and method for preparing a multiple phase confectionery product

2006337617-Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels